Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-043963

EVP and COO sold 356 shares at $15.67 ($5,579)

  • EVP and COO acquired 962 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wolff Stefani EVP and COO 2022-07-30 Option exercise +962 1,594 D: show line 1 in the form
Wolff Stefani EVP and COO 2022-08-01 Sale −356 $15.67 $5,579 1,238 D: show line 2 in the form
Open-market sales · 356 sh · avg $15.67 · $5,579

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Wolff Stefani EVP and COO 2022-07-30 Option exercise · Restricted Stock Units −962 13,468 D: show line 3 in the form
Loading xslF345X03/doc4.xml…